Evotec SE (Evotec SE) Beginning Cash Position : $544.6 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Evotec SE Beginning Cash Position?

Evotec SE's Beginning Cash Position for the quarter that ended in Dec. 2023 was $544.6 Mil.

Evotec SE's quarterly Beginning Cash Position increased from Jun. 2023 ($0.0 Mil) to Sep. 2023 ($490.7 Mil) and increased from Sep. 2023 ($490.7 Mil) to Dec. 2023 ($544.6 Mil).

Evotec SE's annual Beginning Cash Position increased from Dec. 2021 ($477.5 Mil) to Dec. 2022 ($740.8 Mil) but then declined from Dec. 2022 ($740.8 Mil) to Dec. 2023 ($452.7 Mil).

Evotec SE Beginning Cash Position Historical Data

The historical data trend for Evotec SE's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evotec SE Beginning Cash Position Chart

Evotec SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

121.17

337.03

477.49

740.81

452.73

Evotec SE Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															690.09	491.43	-	490.66	544.56

Evotec SE Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Evotec SE Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Evotec SE's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Evotec SE (Evotec SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (NAS:EVO) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

EVOTF:USA 1EVT:Italy EVTd:UK 0IRF:UK EVT:Germany EVT:Germany EVT:Germany EVT:Germany EVTA:Germany EVT:Austria

Address

Essener Bogen 7, Manfred Eigen Campus, Hamburg, DEU, 22419

Website

https://www.evotec.com

Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally and through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.